Synapse - Works

Results (352)

DNMT3A R882 mutation promote chemoresistance and therapeutic relapse through impaired DNA-damage sensing

Meeting Abstract

Guryanova, O.; Shank, K.; Garrett-Bakelman, F.; Spitzer, B.; Ganzel, C.; Rapaport, F.; Keller, M.; Evangelista, L.; Glass, J.; Rowe, J.; more...
Haematologica (2015)

Fulltext@MSK | Save

BCl6 and EZH2 cooperate to assemble non-canonical PRC1-BCOR complex to mediate germinal center formation and promote lymphomagenesis by repressing bivalent chromatin domains

Meeting Abstract

Béguelin, W.; Teater, M.; Hatzi, K.; Jiang, Y.; Gascoyne, R. D.; Abdel-Wahab, O.; Shaknovich, R.; Bardwell, V. J.; Elemento, O.; Melnick, A. M.
Haematologica (2015)

Fulltext@MSK | Save

Outcomes of allogeneic hematopoietic cell transplantation (HCT) in patients with myelofibrosis (MF) exposed to JAK1/2 inhibitors

Meeting Abstract

Shanavas, M.; Popat, U.; Michaelis, L. C.; Fauble, V.; McLornan, D.; Klisovic, R.; Mascarenhas, J.; Tamari, R.; Arcasoy, M.; Davies, J.; more...
Haematologica (2015)

Fulltext@MSK | Save

A phase 1 trial of CUDC-907, an oral, first-in-class, dual inhibitor of HDAC and PI3K, in patients with refractory or relapsed lymphoma and multiple myeloma

Meeting Abstract

Oki, Y.; Berdeja, J.; Patel, M.; Flinn, I.; Gerecitano, J.; Neelapu, S.; Copeland, A.; Akins, A.; Clancy, M.; Viner, J.; more...
Haematologica (2015)

Fulltext@MSK | Save

Elevated hemoglobin concentration and risk of acute myocardial infarction and venous thromboembolism

Meeting Abstract

Hultcrantz, M.; Modlitba, A.; Vasan, S. K.; Sjolander, A.; Rostgaard, K.; Landgren, O.; Hjalgrim, H.; Kristinsson, S. Y.; Edgren, G.
Haematologica (2015)

Fulltext@MSK | Save

Parental longevity and survival in patients with multiple myeloma and MGUS

Meeting Abstract

Sverrisdottir, I. S.; Lund, S. H.; Turesson, I.; Bojrkholm, M.; Goldin, L. R.; Landgren, O.; Kristinsson, S. Y.
Haematologica (2015)

Fulltext@MSK | Save

Family history of lymphoproliferative disease associated with a superior survival in multiple myeloma: A population-based study

Meeting Abstract

Aradttir, K.; Lund, S. H.; Bjorkholm, M.; Goldin, L. R.; Turesson, I.; Landgren, O.; Kristinsson, S. Y.
Haematologica (2015)

Fulltext@MSK | Save

Obesity and risk of monoclonal gammopathy of undetermined significance: A population-based study

Meeting Abstract

Thordardottir, M.; Lindqvist, E.; Lund, S. H.; Costello, R.; Burton, D.; Korde, N.; Mailankody, S.; Eiriksdottir, G.; Launer, L. J.; Gudnason, V.; more...
Haematologica (2015)

Fulltext@MSK | Save

Minimum follow-up of 4 years for ongoing patients with chronic-phase chronic myeloid leukemia (CP-CML) in a phase 1 trial of ponatinib

Meeting Abstract

Talpaz, M.; Cortes, J. E.; Kantarjian, H. M.; Shah, N. P.; Bixby, D. L.; Flinn, I. W.; O'Hare, T. J.; Hu, S.; Rivera, V. M.; Clackson, T.; more...
Haematologica (2015)

Fulltext@MSK | Save

Long-term follow-up of ponatinib efficacy and safety in patients (PTS) with the T315I mutation in the phase 1 and phase 2 (PACE) trials

Meeting Abstract

Baccarani, M.; Mauro, M. J.; Cortes, J. E.; Hochhaus, A.; Hughes, T. P.; Guilhot, F.; Deininger, M. W.; Kantarjian, H. M.; Shah, N. P.; Bixby, D.; more...
Haematologica (2015)

Fulltext@MSK | Save